<?xml version="1.0" encoding="UTF-8"?>
<p>ARDS is the most common medical complication seen with SARS-CoV-2, and it contributes to a significant amount of the morbidity and mortality associated with the illness. Therefore, it is considered the hallmark immune-mediated clinical consequence [
 <xref rid="REF15" ref-type="bibr">15</xref>]. Other complications include shock, acute kidney injury, acute cardiac injury, liver dysfunction, coagulopathy, infection, and even thrombotic disease in otherwise low-risk patients [
 <xref rid="REF17" ref-type="bibr">17</xref>-
 <xref rid="REF19" ref-type="bibr">19</xref>]. The proportion of patients experiencing each of these complications has been outlined in Table 
 <xref rid="TAB1" ref-type="table">1</xref>. These complications are experienced at higher proportions among severe SARS-CoV-2 cases and therefore serve as major contributors to both intensive care unit (ICU) admission and overall mortality [
 <xref rid="REF17" ref-type="bibr">17</xref>-
 <xref rid="REF19" ref-type="bibr">19</xref>].
</p>
